![]() |
市場調查報告書
商品編碼
2147372
高階推車式超音波:裝置量管理、更換週期、平均售價(ASP)降低、全球系統詳細細分市場分析,2024-2035 年Premium and Cart-Based Ultrasound: Installed-Base Control, Replacement Cycles, and ASP Compression, Global Segment Deep Dive, 2024A-2035E |
||||||
本份 Marketstrat® 專題報告深入探討了全球超音波設備市場(推車式機型)中高階、中階及經濟型(高性價比)細分市場,時間跨度涵蓋 2024 年(實際值)至 2035 年(預測值)。報告內容涉及裝機量與設備更新、單一設備收入、服務經濟效益、採購模式、原始設備製造商(OEM)競爭格局,以及美國關稅政策的影響。
與銷售額相比,手推車細分市場的銷售佔有率下降速度更快。本報告認為,該細分市場目前已發展成為成熟的車隊業務,當系統達到使用壽命終點時,價值將返還給持有這些系統的原始設備製造商 (OEM)。
本報告按推車等級、地區和特定國家分析了系統收入、出貨量和裝置量,並檢視了服務線和購買模式的構成比。在預測期(至 2035 年)內,儘管推車的市場佔有率預計會下降,但推車預計仍將佔系統收入的大部分,其中高階推車的成長速度預計最快。
This Marketstrat® Focus Report examines the premium, midrange and value cart tiers of the global ultrasound market from 2024A through 2035E, covering installed base and replacement, revenue per shipment, service economics, purchase models, the OEM competitive set and US tariff exposure.
Carts lose unit share far faster than revenue share. Our view is that the tier now behaves as a mature fleet business, where value accrues to the OEM holding the account when a system reaches end of life.
The report sizes systems revenue, shipments and installed base by cart tier, region and selected country, plus the service line and purchase-model mix. Carts keep the majority of systems revenue through 2035E as unit share falls; premium carts grow fastest.
The report applies the core model's directional share bands and Competitive Signal Scorecard to the systems OEM set, with spotlights on GE HealthCare, Philips, Siemens Healthineers, Mindray, Samsung Medison, Canon Medical Systems, FUJIFILM Sonosite, SonoScape, United Imaging Healthcare and Esaote. Recent FDA clearances widen China-rooted OEMs' US portfolios.
Fleet flows: An installed-base bridge with illustrative useful-life tests.
Price and mix decomposition: Blended and cart ASP change split into mix and segment price effects, globally and by region.
Markintel® frameworks: M³ Market Momentum Matrix, M-TEM and the Upgrade & Package Ladder.
Post-baseline evidence: FDA 510(k) decisions from April to September 2026, US tariff status, a delta-to-baseline assessment, signposts and recommended actions.
The report separates shipment mix from segment price, derives fleet turnover from the model's own flow identity, labels every figure as a published value, derivation, verified fact or judgment, and says plainly where cart-level data cannot support a conclusion.